Back to Search
HOLLY BURT, MD
MD
Family Medicine Physician
NPI: 1578200242IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
94-10927(KS)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Class of 2022
Research & Publications (20)
Calcium pyrophosphate dihydrate crystal-induced inhibition of neutrophil apoptosis: involvement of Bcl-2 family members.
PMID 19669391·Inflamm Res·2010
8-other
Intra-articular drug delivery systems: Overcoming the shortcomings of joint disease therapy.
PMID 19236205·Expert Opin Drug Deliv·2009
6-review
Composite hydrogel formulations of stratifin to control MMP-1 expression in dermal fibroblasts.
PMID 19533306·Pharm Res·2009
8-other
Effects of continuous and pulsatile PTH treatments on rat bone marrow stromal cells.
PMID 19338754·Biochem Biophys Res Commun·2009
7-preclinical
Intra-articular treatment of inflammatory arthritis with microsphere formulations of methotrexate: pharmacokinetics and efficacy determination in antigen-induced arthritic rabbits.
PMID 19266262·Inflamm Res·2009
7-preclinical
PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections.
PMID 19384471·Pharm Res·2009
8-other
Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.
PMID 19007363·BJU Int·2009
7-preclinical
Controlled release of alendronate from polymeric films.
PMID 19323882·J Biomater Sci Polym Ed·2009
7-preclinical
In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators.
PMID 18977029·Biomaterials·2009
8-other
In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
PMID 18762253·Eur J Pharm Biopharm·2009
8-other
Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
PMID 18623213·J Pharm Sci·2009
7-preclinical
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
PMID 18384637·BJU Int·2008
7-preclinical
Enhanced gap filling and osteoconduction associated with alendronate-calcium phosphate-coated porous tantalum.
PMID 18451402·J Bone Joint Surg Am·2008
7-preclinical
Unimolecular micelles based on hydrophobically derivatized hyperbranched polyglycerols: ligand binding properties.
PMID 18247528·Biomacromolecules·2008
8-other
Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
PMID 18384625·BJU Int·2008
7-preclinical
Clusterin antisense complexed with chitosan for controlled intratumoral delivery.
PMID 17890029·Int J Pharm·2008
8-other
The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors.
PMID 17701176·Cancer Chemother Pharmacol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1121 S CLIFTON AVE
WICHITA, KS 67218 - Phone
- (316) 689-5500
Quick Facts
- NPI
- 1578200242
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile